Proposal of an obesity classification based on weight history : an official document by the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society for the Study of Obesity and Metabolic Syndrome (ABESO)

Obesity is a chronic disease associated with impaired physical and mental health. A widespread view in the treatment of obesity is that the goal is to normalize the individual's body mass index (BMI). However, a modest weight loss (usually above 5%) is already associated with clinical improvement, while weight losses of 10%-15% bring even further benefits, independent from the final BMI. The percentage of weight reduction is accepted as a treatment goal since a greater decrease in weight is frequently difficult to achieve due to metabolic adaptation along with environmental and lifestyle factors. In this document, the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society for the Study of Obesity and Metabolic Syndrome (ABESO) propose a new obesity classification based on the maximum weight attained in life (MWAL). In this classification, individuals losing a specific proportion of weight are classified as having "reduced" or "controlled" obesity. This simple classification - which is not intended to replace others but to serve as an adjuvant tool - could help disseminate the concept of clinical benefits derived from modest weight loss, allowing individuals with obesity and their health care professionals to focus on strategies for weight maintenance instead of further weight reduction. In future studies, this proposed classification can also be an important tool to evaluate possible differences in therapeutic outcomes between individuals with similar BMIs but different weight trajectories.

Errataetall:

CommentIn: Arch Endocrinol Metab. 2022 Apr 28;66(2):135-136. - PMID 35482450

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:66

Enthalten in:

Archives of endocrinology and metabolism - 66(2022), 2 vom: 28. Apr., Seite 139-151

Sprache:

Englisch

Beteiligte Personen:

Halpern, Bruno [VerfasserIn]
Mancini, Marcio C [VerfasserIn]
de Melo, Maria Edna [VerfasserIn]
Lamounier, Rodrigo N [VerfasserIn]
Moreira, Rodrigo O [VerfasserIn]
Carra, Mario K [VerfasserIn]
Kyle, Theodore K [VerfasserIn]
Cercato, Cintia [VerfasserIn]
Boguszewski, Cesar Luiz [VerfasserIn]

Links:

Volltext

Themen:

Consensus Development Conference

Anmerkungen:

Date Completed 02.05.2022

Date Revised 15.03.2023

published: Print-Electronic

CommentIn: Arch Endocrinol Metab. 2022 Apr 28;66(2):135-136. - PMID 35482450

Citation Status MEDLINE

doi:

10.20945/2359-3997000000465

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM339497548